390 related articles for article (PubMed ID: 8020050)
1. [From myocardial hypertrophy to heart failure: role of the interstitium].
Barsotti A; Dini FL; Nardini V; Di Muzio M; Gallina S; Di Napoli P; Calafiore AM; Trevi G
Cardiologia; 1993 Dec; 38(12 Suppl 1):67-77. PubMed ID: 8020050
[TBL] [Abstract][Full Text] [Related]
2. Myocardial collagen matrix remodeling and congestive heart failure.
Brilla CG; Rupp H
Cardiologia; 1994 Dec; 39(12 Suppl 1):389-93. PubMed ID: 7634301
[TBL] [Abstract][Full Text] [Related]
3. [Cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertensive heart disease].
Funck RC; Wilke A; Rupp H; Maisch B; Brilla CG
Herz; 1995 Oct; 20(5):330-9. PubMed ID: 7498880
[TBL] [Abstract][Full Text] [Related]
4. [Role of interstitial myocardium in ischemia-reperfusion injury: experimental data and clinical implications].
Barsotti A; Di Napoli P; Di Girolamo E; Di Muzio M; Vitullo P; Dini FL; Gallina S; Modesti A
Cardiologia; 1994 Dec; 39(12 Suppl 1):381-8. PubMed ID: 7634300
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of heart failure following myocardial infarction.
Struthers AD
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
[TBL] [Abstract][Full Text] [Related]
6. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
7. Influence of drug therapy on myocardial hypertrophy in left ventricular failure.
Taylor SH
J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S141-7. PubMed ID: 2485020
[TBL] [Abstract][Full Text] [Related]
8. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
Motz W; Scheler S; Strauer BE
Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
[TBL] [Abstract][Full Text] [Related]
9. Reduced subendocardial coronary reserve. A potential mechanism for impaired diastolic function in the hypertrophied and failing heart.
Vatner SF; Shannon R; Hittinger L
Circulation; 1990 Feb; 81(2 Suppl):III8-14. PubMed ID: 2137053
[TBL] [Abstract][Full Text] [Related]
10. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
Creemers EE; Pinto YM
Cardiovasc Res; 2011 Feb; 89(2):265-72. PubMed ID: 20880837
[TBL] [Abstract][Full Text] [Related]
13. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium.
Weber KT; Clark WA; Janicki JS; Shroff SG
J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S37-50. PubMed ID: 2485029
[TBL] [Abstract][Full Text] [Related]
14. [The significance of myocardial hypertrophy in heart failure].
Holtz J
Z Kardiol; 1992; 81 Suppl 4():41-8. PubMed ID: 1290305
[TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.
Brilla CG; Rupp H; Funck R; Maisch B
Eur Heart J; 1995 Dec; 16 Suppl O():107-9. PubMed ID: 8682074
[TBL] [Abstract][Full Text] [Related]
16. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
Gradman AH; Alfayoumi F
Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
[TBL] [Abstract][Full Text] [Related]
17. Myocardial fibrosis and the renin-angiotensin-aldosterone system.
Weber KT; Brilla CG
J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S48-54. PubMed ID: 1380619
[TBL] [Abstract][Full Text] [Related]
18. The cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertension and heart failure.
Brilla CG
Curr Opin Cardiol; 1994 Jul; 9 Suppl 1():S2-10; discussion S10-1. PubMed ID: 7827369
[TBL] [Abstract][Full Text] [Related]
19. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
Weber KT; Brilla CG
Circulation; 1991 Jun; 83(6):1849-65. PubMed ID: 1828192
[TBL] [Abstract][Full Text] [Related]
20. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
